MDS Sciex Signs Distribution Agreement with D.I Biotech for Korean Market

MDS Sciex and D.I Biotech, a leading biotechnology instrumentation and supplies distribution company, announced the signing of a distributorship agreement to deliver the NanoLC system in Korea. "As a leading supplier to the prospering Korean biotechnology market place, we are very pleased to represent a company and product line as prestigious as MDS Sciex," said MyungSoo Kim, President and CEO of D.I Biotech, "We believe that with our experience, knowledge and relationships in Korean biotechnology marketplace this relationship will bring true benefit to all parties, especially our customers." "D.I Biotech is a prominent company with strong market distribution and customer support expertise. The company provides Life Sciences product offerings, which compliment the NanoLC technology," said Murray Wigmore, Senior Vice President of MDS Sciex Sales and Marketing, "We are pleased to have D.I Biotech as our distribution partner for the NanoLC product line in Korea."

Other news from the department

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics